Phase 1 Malignant Melanoma Clinical Trials
12 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–12 of 12 trials
Recruiting
Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Triple-Negative Breast CancerNon-small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+2 more
Compass Therapeutics85 enrolled9 locationsNCT06150664
Recruiting
Phase 1Phase 2
An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
Endometrial CancerGastric (Stomach) CancerNSCLC (Advanced Non-small Cell Lung Cancer)+2 more
Beijing Tide Pharmaceutical Co., Ltd266 enrolled3 locationsNCT07371663
Recruiting
Phase 1
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Urothelial Carcinoma+2 more
LG Chem76 enrolled1 locationNCT06332755
Recruiting
Phase 1Phase 2
Modified Vaccine for High Risk or Low Residual Melanoma Patients
Malignant Melanoma
Hadassah Medical Organization50 enrolled1 locationNCT01898039
Recruiting
Phase 1
A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
Solid TumorsHepatocellular Carcinoma (HCC)Malignant Melanoma+1 more
Chiome Bioscience Inc.66 enrolled5 locationsNCT06636435
Recruiting
Phase 1Phase 2
AMT-253 in Patients With Advanced Solid Tumours
Advanced Solid TumorsMalignant Melanoma
Multitude Therapeutics Inc.96 enrolled1 locationNCT06209580
Recruiting
Phase 1Phase 2
RAPA-201 Therapy of Solid Tumors
Head and Neck CancerEsophageal Squamous Cell CarcinomaSolid Tumor+6 more
Rapa Therapeutics LLC37 enrolled1 locationNCT05144698
Recruiting
Phase 1
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
SarcomaSCLCMalignant Melanoma+1 more
Y-mAbs Therapeutics60 enrolled8 locationsNCT05130255
Recruiting
Phase 1Phase 2
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Breast CancerColorectal, CancerCervical Cancer+3 more
GeneMedicine Co., Ltd.125 enrolled4 locationsNCT06265025
Recruiting
Phase 1
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Triple-Negative Breast CancerColorectal, CancerGastric Cancer+6 more
BioEclipse Therapeutics60 enrolled3 locationsNCT04282044
Completed
Phase 1
Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma
Malignant Melanoma
Lipotek Pty Ltd24 enrolled1 locationACTRN12610000149066
Completed
Phase 1
Phase 1 Study of Coxsackievirus A21 for the treatment of melanoma
Malignant Melanoma
Viralytics Ltd.3 enrolled1 locationACTRN12605000636651